Junior Financial Analyst - Manufacturing

Resonant Clinical Solutions and Haier Biomedical have launched a benchtop centrifuge using natural refrigerant for clinical trials. The LX-60T100R employs hydrocarbon cooling instead of fluorinated greenhouse gases, complying with upcoming European and US legislation more than two years ahead of deadlines. The centrifuge reduces refrigerant global warming potential from over 1,400 in legacy systems to approximately 3. Key features include rapid pre-cooling to 4°C in five minutes, a 7-inch touchscreen, and quiet operation at 52 dB(A). The device is designed for pharmaceutical sponsors and contract research organisations, supporting blood collection tubes and containers up to 100ml. Clinical trial sponsors can purchase or rent the LX-60T100R exclusively from Resonant through November 2027, with the 220–240V model immediately available and the 110V version launching in Q1 2027.

Resonant Clinical Solutions expands its global activities in medical equipment and accessories through the acquisition of Labfish. Oct 02, 2026, 19:43 ET This acquisition strengthens Resonant's presence in Europe and brings it specialized calibration expertise, IOR/EOR coverage, as well as partner depots to support the clinical trial lifecycle globally LEESBURG, Virginia, October 3, 2026 /PRNewswire/ - Resonant Clinical Solutions ("Resonant"), a global partner specializing in clinical solutions serving life sciences organizations throughout the clinical supply chain and sample lifecycle, today announced it has acquired the German company labfish rental solutions GmbH ("Labfish") and its U.S. and UK subsidiaries, which together provide comprehensive clinical and laboratory equipment rental and calibration solutions. This acquisition expands the European presence of Resonant's Equipment and Accessories (E&A) business and enables it to better meet the needs of increasingly complex clinical trial programs around the world, through highly sought-after specialized expertise. Based in Hamburg, Germany, Labfish offers a wide selection of laboratory equipment for rent, including balances, freezers, refrigerators, infusion pumps, and monitors, as well as kits, consumables, and leading in-house calibration expertise. Labfish also offers importer of record (IOR) and exporter of record (EOR) services, as well as premium logistics management ensuring direct-to-patient delivery. The company collaborates with partner warehouses in Argentina, Israel, Turkey, and China to supply clinical trial sites in more than 70 countries. Founded in 2014, Labfish is ISO 9001 certified and operates one of the largest in-house calibration centers serving clinical trials in Europe. "The integration of Labfish within Resonant's E&A division allows us to expand our presence in Europe and strengthen our calibration and import-export services, further enhancing the world-class clinical trial solutions our clients rely on," said Christophe Berthoux, CEO of Resonant Clinical Solutions. "This acquisition continues the success of our Equipment and Accessories business, in order to meet the constantly evolving needs of our clients. The capabilities Labfish brings to Resonant enable us to advance our strategy of further supporting the clinical journey globally." The increasing complexity of clinical trial programs requires specialized equipment, calibration operations, and logistics support capable of adapting to evolving research protocols, workflows, and requirements. To meet this need, the acquisition of Labfish complements Resonant's existing E&A business, offering its partner clients a robust offering and technical expertise in Europe as their development programs scale. "Joining Resonant allows our team to further develop the calibration expertise, warehouse network, and import-export and logistics services that we have spent years establishing, while now having the necessary means to further support the clinical trial journey," said Martin Forster, founder of Labfish. "We are delighted to bring Resonant our technical expertise, strategic services, and valuable relationships with our clients." Financial terms of the transaction were not disclosed. About Resonant Clinical Solutions Resonant Clinical Solutions is a global partner specializing in clinical solutions, serving life sciences companies across the entire clinical supply chain and sample lifecycle. Through its biobanking, kit preparation, and equipment and supplies activities, Resonant helps its clients manage complexity, reduce risk, and support essential clinical programs around the world. With more than 850 employees across the United States, the United Kingdom, and Europe, Resonant has contributed to the completion of more than 2,500 clinical trials, has ensured more than 20,000 shipments to its clients' sites, and manages more than 100 million research assets in storage. The company works with pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), as well as diagnostic and reference laboratories. Resonant's mission is to provide its partners with comprehensive and global clinical supply chain and sample lifecycle management solutions that simplify their processes and allow them to focus on scientific research and patients. For more information, visit resonantclinical.com.